Test of Herceptin Finds Briefer Treatment Might Work, With Fewer Side Effects
An aggressive form of breast cancer — HER2-positive tumors — often shrink with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good option.
Read more on NPR
Làm đẹp Blog 247 May 17, 2018 at 04:05AM
Category Health & Science
Không có nhận xét nào:
Đăng nhận xét